Researcher

Pardis Sabeti

Profile

Institution

Harvard University / Broad Institute

Field

Computational Genomics / Infectious Disease

Pardis Sabeti developed statistical algorithms for detecting recent positive selection in the human genome and was the first to use real-time genomic sequencing to track Ebola during the 2014 epidemic. She co-founded Sherlock Biosciences to commercialize CRISPR-based nucleic acid detection. A MacArthur Fellow and HHMI investigator, she also fronts the rock band Thousand Days.

Industry Ties

Industry Ties

Sherlock BiosciencesVerily Life SciencesChan Zuckerberg Biohub

Verified employment, education, publications and profile data sourced from ORCID. Locked — unlock to view.